RAD BIOMED’S VGS TO PRESENT AT TCT 2010
-- VGS to show the latest preclinical results for its FLUENT device --
Tel Aviv, Israel, September 21st, 2010 – RAD BioMed, a leading success-accelerator for Israeli life science startups, today announced that its portfolio company, Vascular Graft Solutions (VGS), has been invited to present this year’s TCT (Transcatheter Cardiovascular Therapeutics) conference in Washington DC.
Vascular Grafts Solution will present the preclinical results of its FLUENT external support for saphenous vein grafts in the Novel Technologies section of the Advanced Surgical Techniques and Technologies Session. TCT (Transcatheter Cardiovascular Therapeutics) is the world's largest educational meeting specializing in interventional cardiovascular medicine.
Eyal Orion, Vascular Graft Solutions’ co-founder and CEO said: “It’s a great honor to be invited to present our latest results at this year’s TCT. The preclinical studies performed until now show that the FLUENT is extremely surgeon-friendly and reduces significantly intimal hyperplasia, which is the main factor for late stage vein graft failure in CABG procedures.
About RAD BioMed
RAD BioMed is a success-accelerator for Israeli life science startups. With state-of-the-art facilities, a team of entrepreneurial experts and broad contact networks, RAD BioMed incubates startups at various stages in the medical devices, biopharma and diagnostic sectors. The Tel-Aviv-based accelerator empowers innovation by ‘de-risking’ the start-up process and providing comprehensive support, including funding, mentoring and umbrella business development, marketing and administration services. RAD BioMed is the sole incubator in Israel to provide its portfolio companies with access to state-of-the-art biotechnology laboratories. RAD BioMed is owned by Yehuda Zisapel, President and Founder of the RAD Group, a world leader in voice and data communications technologies, and Professor Nava Zisapel, founder of Neurim Ltd., one of Israel’s leading BioPharma companies. RAD BioMed’s professional staff includes seasoned entrepreneurs and veteran professionals with broad experience in finance, medicine and biotechnology.